NCT06150209View on ClinicalTrials.gov

A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje.

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

June 15, 2025

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

Vendaje

Dehydrated Human Amniotic Membrane

Sponsors
All Listed Sponsors
lead

BioStem Technologies

INDUSTRY

NCT06150209 - A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje. | Biotech Hunter | Biotech Hunter